Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Omar Hasan Ali

Has grant

PI Glycodermatology

University of Zurich

Switzerland

Research Interests

Explore related searches

Professors in Switzerland Professors in Immunology Immunology professors in Switzerland

Recent Grants

Grant: Close

Glycoproteomics

Open Date: 2020-07-01

Close Date:

Articles (7)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Collaborators (10)

Wolfgang Boehmerle

Charite Universitatsmedizin Berlin Klinik für Neurologie mit Experimenteller Neurologie

GERMANY

View details

Christine Stadelmann

GERMANY

View details

Martin Brutsche

Prof

Kantonsspital St. Gallen

SWITZERLAND

View details

Raphael Mohr

Charité - Universitätsmedizin Berlin

GERMANY

View details

Silvio Daniel Brugger

University of Zurich

SWITZERLAND

View details

Jonas Franz

Neuropathologist

University of Göttingen

GERMANY

View details

Anja Heider

University of Tübingen

GERMANY

View details

Willem van de Veen

SWITZERLAND

View details

Philipp Kohler

Senior Researcher

University of Zurich

SWITZERLAND

View details

Burkhard Becher

University of Zurich

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Omar Hasan Ali

Research Interests

Explore related searches

Recent Grants

Articles (7)

HLA-A01:01-B08:01-C*07:01 is linked to early-onset immune checkpoint inhibitor-induced myositis and myocarditis

Neoadjuvant Therapy in Resectable Advanced Melanoma: Swiss Real-World Data

Correction: Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19

Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19

Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors

Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients

Pulmonary Surfactant Proteins are Inhibited by IgA Autoantibodies in Severe COVID-19.

Collaborators (10)

Wolfgang Boehmerle

Christine Stadelmann

Martin Brutsche

Raphael Mohr

Silvio Daniel Brugger

Jonas Franz

Anja Heider

Willem van de Veen

Philipp Kohler

Burkhard Becher

Make your next move.

Omar Hasan Ali

Research Interests

Explore related searches

Recent Grants

Articles (7)

HLA-A*01:01-B*08:01-C*07:01 is linked to early-onset immune checkpoint inhibitor-induced myositis and myocarditis

Neoadjuvant Therapy in Resectable Advanced Melanoma: Swiss Real-World Data

Correction: Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19

Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19

Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors

Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients

Pulmonary Surfactant Proteins are Inhibited by IgA Autoantibodies in Severe COVID-19.

Collaborators (10)

Wolfgang Boehmerle

Christine Stadelmann

Martin Brutsche

Raphael Mohr

Silvio Daniel Brugger

Jonas Franz

Anja Heider

Willem van de Veen

Philipp Kohler

Burkhard Becher

Make your next move.

HLA-A01:01-B08:01-C*07:01 is linked to early-onset immune checkpoint inhibitor-induced myositis and myocarditis